The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory studyMary R. Lee, Lorenzo Leggio, Lisa A. Farinelli et al.|Molecular Psychiatry|2018Cited by 127